compared to total revenue from medical treatment for the fiscal year 2018 and 2019, equaled to 70.5% and 81.4% respectively. The major proportion in cost of medical treatments were derived from cost incurred

incurred a net loss of Baht 834 million in 2018, compared with the year 2017 with a net profit of Baht 990 million, however, the Company’s EBITDA was still remain positive at Baht 612 million in 2018. 3

the above reason, the Company has incurred a net loss of Baht 836 million in 2018, compared with the year 2017 with a net profit of Baht 990 million, however, the Company’s EBITDA was still remain

is because in Q3- 2022, the allowance for expected credit losses incurred from long- standing receivables and the loss on fair value adjustments of equity investments higher than other quarters were

. • Dividend paid Baht 16.80 million. Page 5 of 19 The analysis of operating result for six months Comparing accumulated operating results for 6 months with the same period of the prior year, the group’s profits

million and some portion from the trade creditors agreed to reduce the accrued interests payable during the negotiation period before the completed debt-to-equity conversion scheme. - Gain on exchange rate

the net trade debts of THB 1,136 million and some portion from the trade creditors agreed to reduce the accrued interests payable during the negotiation period before the completed debt-to-equity

. 2.4 Extra expenses incurred in this quarter amounted to Baht 372.33 million 2.4.1The extraordinary expenses incurred in this quarter were provision for doubtful accounts of short-term loans amounting to

increased 2.1% YoY and 1.1% QoQ from slightly higher interest-bearing debt. Net FX gain was Bt41mn compared to Bt67mn in 3Q16 and Bt12mn in 2Q17. FX gain/loss was incurred from CAPEX payables as a result of

loans Claims held by UWC as a creditor in relation to all outstanding loans owed to it by UAB and SBM, together with accrued interest (collectively referred to as the Outstanding Loans) as at the